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Ectopically Expressed CAG Repeats Cause
Intranuclear Inclusions and a Progressive Late
Onset Neurological Phenotype in the Mouse
The context may simply modulate a pathological pro-
cess driven by the repeat itself. This argument is bol-
stered by several striking similarities among the disor-
ders (Ross, 1995; Saudou et al., 1996; Reddy and
Housman, 1997). In each disease (1) the repeat codes
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each disease allele affects different sets of neurons. ForEmory University
example, SBMA primarily affects motor neurons, theAtlanta, Georgia 30329
SCAs primarily affect neurons of the cerebellum, and
HD primarily affects the neurons of the striatum. Second,
symptoms differ markedly, ranging from progressive
Summary motor weakness in SBMA to chorea and dementia in
HD (Ross, 1995). Third, the age of onset for a given
The mutations responsible for several human neuro- repeat length depends on the disease gene. For exam-
degenerative disorders are expansions of translated ple, repeats 70±80 units long are associated with onsets
CAG repeats beyond a normal size range. To address prior to the age of 20 years for HD, DRPLA, and SCA1;
the role of repeat context, we have introduced a 146- however, this same range of length is associated with
unit CAG repeat into the mouse hypoxanthine phos- onsets of 20±40 years of age for SCA3 (Gusella et al.,
phoribosyltransferase gene (Hprt). Mutant mice express 1996; Zoghbi, 1996). These differences suggest that
a form of the HPRT protein that contains a long poly- context plays an important role in the pathology of each
glutamine repeat. These mice develop a phenotype disorder. In fact, the pathology of SCA6 may be the
similar to the human translated CAG repeat disorders. result of the CAG repeat altering the normal function of
Repeat containing mice show a late onset neurological the gene in which it is located, since other types of
phenotype that progresses to premature death. Neu- mutation in this gene affect the same neurons (Zhu-
ronal intranuclear inclusions are present in affected chenko et al., 1997). Elimination of the normal function
mice. Our results show that CAG repeats do not need of the gene is probably not the mechanism underlying
to be located within one of the classic repeat disorder the pathology of the other CAG repeat disorders (re-
genes to have a neurotoxic effect. viewed in Ross, 1995). For example, long CAG repeats
in the androgen receptor gene cause SBMA, where the
Introduction null allele causes testicular feminization rather than
SBMA.
Inheritance of long CAG repeats causes several hu- This comparison of the repeat disorders leaves us with
two contrasting views. First, there may be a universalman neurological disorders including Huntington's dis-
mechanism of pathology driven by the repeat that isease (HD), dentatorubral-pallidoluysian atrophy (DRPLA),
modified somewhat by context, thus creating differ-spinobulbar muscular atrophy (SBMA), and five spino-
ences among the disorders. By this view, a gene iscerebellar ataxias (SCA1, SCA2, SCA3, SCA6, and SCA7)
simply a carrier, and any gene with a long CAG repeat(Saudou et al., 1996; David et al., 1997; Reddy and Hous-
properly expressed might cause pathology (Cha andman, 1997). Although each of these disorders shares a
Dure, 1994). The second view suggests that a specificcommon type of mutation, the mutation is located in a
gene drives the pathology, and the repeats trigger thedifferent locus for each disorder. Comparisons reveal
dysfunction. By the latter view, CAG repeats wouldno structural or functional similarities,with the exception
cause pathology in only a few highly specialized genes,of the CAG repeat in each gene (Reddy and Housman,
and many properly expressed CAG repeats would not1997). It is unclear what role repeat context plays in the
cause pathology. To date, the function of only two of themolecular mechanism or mechanisms of these disorders.
genes is known (SCA6 and SBMA), making conclusions
based on function impossible (Reddy and Housman,
1997).8 To whom correspondence should be addressed.
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Figure 1. Targeted Mutation of Hprt and Ex-
pression of Mutant Protein
(A) Diagram of homologous recombination
between the targeting vector and the wild-type
Hprt locus. Filled boxes represent exons, and
the striped box represents the 146-unit CAG
repeat. Each crossover is represented by a
large X. Thick lines indicate probes. Restric-
tion enzyme sites are marked as follows: B,
BamHI; H, HindIII; E, EcoRI; P, PstI.
(B) Southern blot analysis of ES cell DNA with
probe 1. Lanes contain ES cell DNA from the
parental R1 ES cell line (lanes 1, 4, and 7), or
the targeted ES cell lines eJO13 (lanes 2, 5,
and 8) and eJO18 (lanes 3, 6, and 9). DNA
was digested with PstI (lanes 1±3), BamHI
(lanes 4±6), or HindIII (lanes 7±9). Size stan-
dards are indicated to the left of each panel.
(C) Western blot analysis of ES cell protein
extracts probed with the SL28 antibody. Lane
1 contains protein extract from the R1 ES cell
line. Lane 2 contains protein extract from the
HPRT-deficient HM1 cell line. Lanes 3 and 4
contain protein extracts from the targetedcell
lines eJO13 and eJO18, respectively.
(D) Western blot analysis of protein extracts
from mouse brain probed with the 1C2 mono-
clonal antibody.Lanes 1 and2 contain protein
extract from wild-type and JO1 mouse brains,
respectively.
(E) Western blot analysis of wild-type brain
using the secondary anti-mouse Ig antibody
only.
In order to assess the role of repeat context, we have insertion of the repeat as confirmed by Southern analy-
sis (Figure 1B). The loss of bands representing the wild-inserted a 146-unit CAG repeat into exon 3 of the murine
Hprt gene. The resulting mutant allele (hprt(CAG)146) codes type length fragments in Figure 1B is indicative of gene
targeting, since there is only one copy of the X-linkedfor a full-length HPRT protein with an insertion of a long
polyglutamine stretch near its N terminus. Mice with Hprt gene in the male ES cells used. Increases in the
length of PstI, BamHI (Figure 1B), and EcoRI (not shown)this mutation mimic the human translated CAG repeat
disorders by developing a delayed onset progressive restriction fragments of the Hprt exon 3 region by z500
base pairs show proper insertion of the repeat mutation.neurological phenotype that includes the presence of
NIIs. Thus, CAG repeats need not reside within one of The reduction of the 7.1 kb HindIII fragment to 6.5 kb
(Figure 1B) confirms the insertion of the HindIII site engi-the human translated repeat disorder genes in order to
have a neurotoxic effect. neered just downstream of the repeat. The presence of
only one band ineach lane of Figure 1B rules out a simple
insertion of the targeting construct. Together these dataResults
indicate that ES cell clones eJO13 and eJO18 resulted
from the replacement of wild-type exon 3 Hprt se-Gene Targeting
quences with sequences containing the hprt(CAG)146 mu-In order to control for chromosomal context, gene tar-
tation.geting was used to insert a long CAG repeat into the
murine Hprt locus. CAG repeats were inserted into a
gene-targeting vector (Figure 1A) as described in Ex- Mice Used in This Study
Mouse lines JO1 and JO2 containing the hprt(CAG)146 muta-perimental Procedures. DNA sequencing confirmed the
presence of a pure 146-unit CAG repeat oriented within tion were produced by blastocyst injection of the ES
cell lines eJO18 and eJO13, respectively. JO1 mice werethe Hprt open reading frame so that it codes for a stretch
of 146 glutamines. The targeting vector was electropo- used in this study; however, a few JO2 mice were ana-
lyzed to rule out cell-line specific effects. PCR andrated into R1 ES cells (Nagy et al., 1993). Homologous
recombination between the targeting vector and the ES Southern analysis showed that each mouse in this study
had approximately the same length of CAG repeat (datacell chromosome adds 476 bp to exon 3 of the Hprt
gene and creates a HindIII restriction site immediately not shown). Since the hprt(CAG)146 mutant allele is X-linked,
random inactivation of the X chromosome in heterozy-downstream of the repeat (Figure 1A). One electropora-
tion yielded nine independent 6-thioguanine-resistant gous females would produce mice that expressed
hprt(CAG)146 in some cells but not in others. Therefore,colonies, and two of these lines contained the correct
Ectopically Expressed CAG Repeat in the Mouse
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for this study we analyzed only hemizygous males and
homozygous females. The JO1 line is a mixture of
C57BL/6J and the strain background of R1 ES cells
[(129/Sv 3 129/SvJ)F1]. Wild-type control mice were
age-matched siblings of the JO1 mice. HPRT-deficient
mice (n 5 6)with thedeletion mutation hprtb-m3 (Hooper et
al., 1987) were from a similar mixed genetic background
(C57BL/6J and 129/Ola). This class was supplemented
with HPRT-deficient mice with the same hprtb-m3 mu-
tation of a pure C57BL/6J background (n 5 19). No
striking behavioral differences between mixed and in-
bred hprtb-m3 mice were observed. Although the JO1 and
wild-type mice were age matched, and some observa-
tions were made on these mice as early as 8 weeks of
age, the hprtb-m3 mice used in this study were 15±30
weeks of age at the start of observation. Consequently,
the hprtb-m3 mice were used to make comparisons to the
older JO1 and wild-type mice.
Figure 2. Representative Cortical EEG Recordings from JO1 and
Control MiceExpression of Mutant HPRT
Western blot analysis was performed on cell extracts The top three traces were recorded during a 1 min tail suspension
stimulation. Vertical arrows represent the beginning and end of thefrom the targeted ES cell lines (Figure1C). SL28, a mono-
tail suspension. The horizontal arrow represents the duration ofclonal antibody that binds to polyglutamine repeats
seizure in the JO1 mouse. The bottom trace was recorded from the(Lobo Ruppert et al., 1996), recognized a protein with
same JO1 mouse without stimulation. Handling artifacts due to the
an apparent molecular weight of approximately 58 kDa mice being picked up by the tail are labeled HA.
in the targeted cell lines (lanes 3 and 4), but not in the
parental R1 cell line (lane 1) or the HPRT-deficient ES
sometimes caused a convulsive spell. These convul-
cell line HM1(lane 2). A band at 58kDa was also detected
sions started an average of 36 s after suspending a
on Western blots (not shown) of eJO13 and eJO18 protein mouse by the tail and lasted an average of 42 s. EEG
probed with an anti-HPRT antibody and the anti-polyglu- recording using cortical surface electrodes on six JO1
tamine antibody 1C2 (Trottier et al., 1995). Furthermore, mice confirmed the presence of seizures (Figure 2). Con-
a band of the same size was detected in JO1-mutant trol animals (four wild-type and two hprtb-m3 mice) had
brains (Figure 1D, lane 2), but not in wild-type mouse baseline EEG recordings (Figure 2). Seizures were ob-
brains (Figure 1D, lane 1), by Western analysis of total served in 33 of 385 trials of JO1 mice older than 18
brain protein using the 1C2 antibody as a probe. The weeks and were not seen in 135 trials of JO1 mice 18
SL28 antibody gave similar results (data not shown). weeks or younger. Seizures werenever observed inwild-
The additional 65 kDa protein detected in mouse brain type mice (240 trials) or in hprtb-m3 controls (607 trials).
extracts (Figure 1D) is an artifact produced by direct To provide statistical comparisons of mice, they were
binding of the secondary anti-mouse Ig antibody as classified as being susceptible to seizures if seizures
shown by Western analysis without the primary 1C2 were observed during any trial and as not having sei-
antibody (Figure 1E). zures if they failed to have a seizure in a minimum of
The apparent molecular weight of the 58 kDa mutant- seven trials. These classifications (Table 1) show that
specific band is approximately 10 kDa more than the significantly more JO1 mice are susceptible to having
molecular weight predicted by the addition of 146 gluta- seizures than controls. Furthermore, significantly more
mine residues to the HPRT protein. This difference is old (.18 weeks) than young JO1 mice were categorized
not due to alterations of mRNA size, since Northern as being susceptible to seizures. The lack of seizures
analysis of total RNA from the targeted ES cell line eJO18 in hprtb-m3 mice confirms prior work (Jinnah et al., 1991).
revealed a 2.1 kb transcript that is predicted by the Since a mouse tending to have seizures would, on
addition of the approximately 0.5 kb mutation to the 1.6 average, have a seizure in only one of ten trials, the
kb HPRT mRNA (data not shown). The slower migration number of mice classified as tending to have seizures
of the mutant protein is consistent with results obtained is most likely an underestimate. Therefore, seven of the
for other proteins with long polyglutamine repeats JO1 mice were assayed beyond the initial trials to deter-
(Reddy and Housman, 1997). Our ability to detect, with mine how many would have a seizure at some point in
three different antibodies, a protein specific to both tar- their life. At the end of 21 weeks of age, four of the
geted ES cells and the brains of JO1 mice shows that seven mice had experienced at least one seizure, and
the mutant allele can be transcribed and translated. by 35 weeks of age all seven of this group had at least
one seizure. This data suggests a high penetrance for
seizure susceptibility in JO1 mice. Seizures were also
Behavioral Characteristics seen in hprt(CAG)146 mice derived from an independent ES
Wild-type, JO1, and hprtb-m3 mice were assessed by a cell clone. Together these data show that the CAG re-
battery of behavioral tests (described below) that re- peat inserted into the Hprt gene causes a late onset
susceptibility to seizures.quired suspension of the mice. Handling of theJO1 mice
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Table 1. Behavioral Classification of JO1, Wild-type, and hprtb-m3 mice
Open Cage Falling from Falling from
Seizure Clasping Escaping Inactivity Rotarod (trials 5±7) Rotarod (trials 8±10)
JO1 #18 weeks 0/14 3/15 3/15 1/4 Ð 0/4
(P 5 0.018) (P 5 0.006) (P 5 0.526) (P 5 0.087) (P 5 0.021)
JO1 .18 weeks 10/30 7/8 0/8 20/27 14/15 17/25
Wild type #18 weeks 0/6 0/5 4/5 0/3 Ð Ð
Wild type .18 weeks 0/13 2/9 7/9 1/13 1/10 Ð
(P 5 0.02) (P 5 0.015) (P 5 0.002) (P 5 0.0001) (P , 0.0001)
hprtb-m3 .18 weeks 0/25 0/21 20/21 1/25 3/22 Ð
(P 5 0.001) (P , 0.0001) (P , 0.0001) (P , 0.0001) (P , 0.0001)
Data presented as the number of mice exhibiting each characteristic over the total number of mice in each group. See text for description
of classification criteria. P values were calculated by Fisher exact test and represent comparison of each group to JO1 mice older than 18
weeks.
Mice were suspended by the tail for 1 min at a height Mice were classified as tending to fall if they fell during
two or three of the three trials. These data (Table 1)of 35 cm then slowly lowered and released upon reach-
ing the cage floor. Mice either struggled with limbs out- indicate that more old JO1 mice tended to fall than old
wild-type or old HPRT-deficient mice. Figure 3C alsostretched and moving, hung without struggling, or drew
limbs against the abdomen (clasping). Clasping was ei- shows that young JO1 mice improved in performance
up to the eighth trial and remained consistent in laterther intermittent or the limbs were held stationary.
Clasping in JO1 mice prevented the mice from their trials. Therefore, we compared young and old JO1 mice
during trials 8±10. Mice were classified as tending to fallnormal response of reaching for the bottom of the cage
when lowered in 41% of the trials involving clasping. for trials 8±10 if they fell during two or three of the three
trials. Table 1 shows that significantly more old JO1This result suggests that the continuation of clasping
was often involuntary. Figure 3A shows that JO1 mice mice tended to fall than young. These results are consis-
tent with the hprt(CAG)146 mutation causing a late onsetclasped more often as they aged. It also shows that
wild-type mice clasped more often as they aged, but deficit in rotarod performance. Older JO1 mice may sim-
ply be unable to improve from one trial to the next.to a lesser degree than JO1 mice. In order to derive
statistically meaningful comparisons, mice were given Further studies would need to be performed to deter-
mine whether these mice have a cognitive or a motora minimum of five trials and classified as tending to
clasp if clasping was seen in at least one of five trials. deficit.
Mice were housed in cages with filtered lids. OpeningThese classifications (Table 1) reveal that significantly
more old JO1 mice tend to clasp than old wild-type a cage in a laminar flow hood exposed the mouse to
light, increased airflow, and the noise of the hood fan.or old HPRT-deficient mice, suggesting that the CAG
repeat is responsible for this difference. Furthermore, Normally, mice show exploratory behavior when ex-
posed to these conditions. JO1 mice, however, seemedsignificantly more old JO1 mice are classified as tending
to clasp than young JO1 mice. to explore less than controls when the tops of the cages
were removed during routine handling. Therefore, weStruggling during tail suspension sometimes resulted
in the mouse escaping from the trial by climbing onto assessed the response to removal of the lid and food
rack. Inactivity was scored if the mouse did not roamthe observer's fingers. As shown in Figure 3B, JO1 mice
lost the ability to escape tail suspension by 18 weeks, or rear during the first 10 s after opening the cage. As
shown in Figure 3D, JO1 mice had a similar percentagean age when wild-type mice usually escaped. To derive
statistically meaningful comparisons, mice were classi- of active trials as wild-type mice before 18 weeks of
age, but older JO1 mice had progressively fewer activefied as tending to escape if they escaped at least once
in five trials (the minimum number of trials). Significantly trials. Statistical comparisons of open cage results rely
on classification of mice, which is shown in Table 1.fewer old JO1 mice tended to escape than old wild-
type or old HPRT-deficient mice (Table 1). The lack of Each mouse was considered to tend to be inactive if it
had at least one trial scored as inactive per five totala significant difference in number of mice tending to
escape between old and young JO1 mice might be ex- trials (the minimum number of trials). Significantly more
old JO1 mice tended to be inactive in the open cageplained by the deficit in escaping occurring well before
18 weeks of age, as suggested by the data in Figure 3B. than controls. Although the data shown in Figure 3D
suggest a late onset for open cage inactivity, a signifi-These data are consistent with the CAG repeat mutation
causing a deficit in ability to escape a 1 min tail suspen- cant difference between old and young JO1 mice was
not shown by classification. This discrepancy may besion trial at approximately 12 weeks of age.
Mice were placed on a slowly rotating cylinder (the due to having too few young JO1 mice or to some mice
having an onset for this trait later than 18 weeks.rotarod) suspended at a height of 30 cm,and an observer
recorded whether or not the mouse could remain on To address the nature of this inactivity further, we
monitored the activity of mice in the absence of thethe rod for 1 min. As shown in Figure 3C, control mice
dramatically improved in performance and remained stimuli caused by opening the cage in the hood. The
activity of mice in closed cages was assessed by anconsistent by the fifth trial. Thus, a comparison based
on trials 5±7 was chosen for the different mouse lines. infrared beam activity monitor (A. B. Sieber, Rocky
Ectopically Expressed CAG Repeat in the Mouse
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Figure 3. Behavioral Characteristics of the
JO1 Phenotype
(A) Percentage of wild-type (solid bars, n 5
16) or JO1 (open bars, n 5 31) mice that
clasped during the tail suspension test. Each
bar represents at least four trials for each
mouse.
(B) Percentage of wild-type (triangles, n 5
16) or JO1 (open circles, n 5 31) mice that
escaped from tail suspension. Each data
point represents at least five trials.
(C) Percentage of mice that fell from the
rotarodduring trials 1±11. Triangles represent
14 wild-type mice, boxes represent 25 hprtb-m3
mice, open circles represent 26 JO1 mice
8±31weeks of age, andfilled circles represent
a subset of the JO1 mice (n 5 9) from 13 to
21 weeks of age.
(D) Percentage of mice active following re-
moval of the cage top. Solid bars represent
16 wild-type mice (106 trials), and open bars
represent 32 JO1 mice (228 trials).
(E) Number of upper and lower beams broken
by JO1 mice during activity cage monitor ex-
periments. Open bars represent 18 JO1 mice,
filled bars represent 14 wild-type mice, and
hatched bars represent 20 hprtb-m3 mice. 95%
confidence maximum is indicated.
Mount, North Carolina). A total of eight beams spanned JO1 mice had at least 40% fewer upper beam breaks
during the later trial, and the fifth mouse had 10% fewer.the width of each cage. Six evenly spaced lower beams
would be broken by mice normally walking the length Three of the five wild-type mice had more upper beam
breaks in the later trials, and the other two mice hadof the cage (horizontal activity), and two upper beams
located near the cage ends (away from food and water) reductions of 3% and 22%. These data show that JO1
(but not wild-type mice) had progressively less verticalcould only be broken by rearing or climbing upside-
down on the cage rack (vertical activity). A total of 18 activity as they aged. Since each of these JO1 mice had
at least one observed seizure prior to its first trial withold (.18 weeks) JO1, 14 old wild-type, and 20 old hprtb-m3
mice were tested. Mice were given one full day to accli- the photocell monitor, it is unlikely that the observed
reductions reflect an onset of a phenotype between themate to the cage, then beam breaks were continuously
monitored for 5 days and 5 nights. Figure 3E shows that trials. These results are consistent with a progressive
phenotype caused by the repeat mutation.old JO1 mice and old wild-type mice had similar levels of
horizontal activity. Therefore, it is likely that the reduced
activity of old JO1 mice seen in the open cage experi- General Characteristics
The mass of several JO1 and control mice was recordedment is dependent on the removal of the cage lid. JO1
mice, however, broke far fewer upper beams than wild- for several weeks (data not shown). The mass of young
(#18 week) JO1 mice was similar to young wild-type andtype or HPRT-deficient controls (p , 0.01 Kruskal-Wallis
nonparametric ANOVA with Dunn's multiple comparison young hprtb-m3 mice. Older JO1 mice, however, tended to
weigh more than similarly aged wild-type and HPRT-test [K-W w/D]).
A few mice were chosen for additional activity monitor deficient controls. A statistical comparison indicates
JO1 males weighed significantly more than wild-typetrials in order to assess differences in vertical activity
with increasing age of individual mice. Five old (.18 males at 23 weeks of age (p , 0.05; K-W w/D).
Figure 4 shows JO1 mice died at a younger age thanweek) JO1 mice and five old wild-type mice were as-
sessed 4±6 weeks after their first trial. Four of the five wild-type and hprtb-m3 mice, showing that the repeat
Cell
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about possible losses in brain mass caused by the CAG
repeat.
No evidence of neurodegeneration or gliosis was seen
after a thorough examination of brain sections from 11
affected JO1 mice (ages 30±46 weeks, data not shown).
Immunocytochemical analyses of brain sections with an
anti-HPRT antibody revealed a densely staining mass
in the nuclei of many neurons in JO1 mice that is never
seen in control brains (Figure 5). These structures share
several similarities with NIIs recently described in HD,
SCA1, and SCA3 patients and transgenic mouse models
of HD and SCA1 (Davies et al., 1997; DiFiglia et al., 1997;
Paulson et al., 1997; Scherzinger et al., 1997; Skinner
et al., 1997). An identical structure in the nuclei of many
JO1 neurons stains with an anti-ubiquitin antibody (Fig-
ure 5). The typical NII was roughly spherical and approxi-
mately 0.5±0.6 mm in size. One inclusion per cell was
most common, with only 2% of labeled neurons havingFigure 4. Lifespan of JO1 Mice
two NIIs. NIIs were never seen in glial cells but werePercentage of JO1 (solid line, n 5 15), hprtb-m3 (dashed line, n 5 15),
identified in neurons from many brain regions includingand wild-type (dashed line, n 5 17) mice surviving at various ages
is shown. cerebral cortex, septum, striatum, globus pallidus, hy-
pothalamus, thalamus, hippocampus, amygdala, sub-
stantia nigra, superior and inferior colliculi, tegmental
pons, motor and sensory cranial nerve nuclei, and cere-causes premature death. The median age of death for
bellar Purkinje cells. The proportion of neurons with NIIsJO1 mice is 45 weeks, and by 53 weeks all 15 JO1 mice
varied regionally. For example, in the pyramidal layer ofhad died compared to no natural deaths in both wild-
the cerebral cortex approximately 30% of the neuronstype and HPRT-deficient control groups. Six of the JO1
contained NIIs, while in the deepest layer of the cortexmice aged 44±48 weeks were observed to provide a
only 6% of the neurons had inclusions. Similarly, in sub-description of the state of the mouse just prior to death.
stantia nigra NIIs were more common in the pars com-All six JO1 mice experienced frequent jerks of the body,
pacta (52% of neurons) than in the pars reticulata (11%and five of six had a slight resting tremor. A mild ataxia
of neurons). The widespread distribution of these HPRT-characterized by a swaying gait developed in four of the
immunoreactive NIIs defines the minimum scope ofsix JO1 mice, and one mouse developed a severe ataxia
hprt(CAG)146 expression. Therefore, expression of the mu-that would occasionally lead to the mouse falling on its
tant protein is widespread in the brain.side while walking. The tremor preceded the onset of
Electron microscopy confirmed the nuclear locationataxia, which was then typically followed by death within
of the inclusions (Figure 6). Ubiquitin and HPRT-immu-3±6 days. These abnormalities were not observed in the
noreactive NIIs were visible as a mass of diaminobenzi-wild-type or hprtb-m3 controls of the same age nor during
dine (DAB) immunostaining in the nuclei of many neu-observations of JO1 mice ranging from 8 to 32 weeks of
rons distinct from the nucleolus and the accessory bodyage. Five JO1 mice were observed to dieduring seizures.
of Cajal. In immunogold-labeled tissue, the ultrastruc-Two hemizygous male and two homozygous female
ture of the NIIs could be assessed. A cluster of immuno-JO1 mice were sacrificed between 34 and 38 weeks
gold particles localized to a region of the nucleus withof age for histological analyses of all major organs. In
an electron density less than the rest of the nucleus. Thisgeneral, JO1 mice were histologically normal. Neverthe-
region lacked a surrounding membrane and consisted ofless, all four mutants had moderately fatty livers, a find-
filamentous material (Figure 6). Filamentous material ining that was subsequently confirmed by oil red O stain-
NIIs has been shown previously (Davies et al., 1997;ing of the livers of two additional JO1 mice. Fatty livers
DiFiglia et al., 1997). Further analyses of the develop-may be the consequence of the mutant mice having, in
ment and ultrastructure of NIIs are underway.general, more body mass as described above. One of
the two JO1 males had complete atrophy of the testes;
the other male had normal testes. Most JO1 males at
Discussionthis age breed well, suggesting that testicular atrophy
presents with low penetrance or that this finding is coin-
In order to assess the role of repeat context in CAGcidental.
repeat disorders, we have produced mice that express
long CAG repeats outside the context of the repeat dis-
order genes. We then assessed these mice in light ofNeuropathology
Significant overlaps in fixed brain weights occurred be- the known differences and similarities among the repeat
disorders. A phenotype that shares an underlying molec-tween JO1 and wild-type mice between 31 and 34 weeks
of age, suggesting that there were no differences in ular mechanism with the human disorders should be
neurological, have a late onset, should be progressive,brain weight. Nevertheless, it is possible that subtle
differences in brain weights could be detected in older and the onset should be inversely related to the length
of the repeat. Comparisons between old and young JO1mice. At this time, we can make no firm conclusions
Ectopically Expressed CAG Repeat in the Mouse
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Figure 5. Hprt- and Ubiquitin-Positive Nuclear Inclusions in JO1 Mouse Brain
Light micrographs showing HPRT immunoreactivity in the substantia nigra of JO1 (A), hprtb-m3 (B), and wild-type (C) mice, and ubiquitin
immunoreactivity in the cerebral cortex of JO1 (D), hprtb-m3 (E), and wild-type (F) mice using Nomarski optics. Nuclear puncta were only found
in JO1 brains. Scale bar, 25 mm.
mice show a late onset for several abnormalities includ- resting tremor; (4) ataxia; and (5) premature death. Fur-
thermore, a limited study shows that mice with a shortering reductions in open cage activity, tendency to fall
from the rotarod, ataxia, resting tremor, as well as sei- CAG repeat in the hprt locus do not have the phenotype
described for JO1 mice. Nine of nine mice aged 26±35zure susceptibility. Once onset has occurred, the pheno-
type in JO1 mice progresses until death. Symptoms in weeks with a 70 unit CAG repeat in the hprt locus
showed: (1) no seizures (100 trials), (2) tendency to es-JO1 mice accumulate in roughly the following order: (1)
loss of ability to escape from tail suspension and slowing cape tail suspension, and (3) wild-type levels of vertical
activity. Therefore, at ages when JO1 mice have pro-of improvement of rotarod performance; (2) seizures,
clasping, weight gain, reductions in open cage activity, found abnormalities, mice with smaller CAG repeats lack
some and perhaps all of the described symptoms. Weand decreases in vertical activity; (3) frequent jerks and
Figure 6. Electron Micrographs of NIIs in JO1 Mice
(A) An HPRT-immunolabeled cortical neuron. A concentrated mass of DAB staining is found in the nucleus (arrow). Cytoplasmic staining is
also present, but not as a large mass.
(B) An ubiquitin immunolabeled nuclear inclusion of a hypothalamic neuron. The ubiquitin-labeled inclusion (arrow) is distinct from the nucleolus
(star).
(C) Immunogold labeled nuclear inclusion in cortical neuron. Immunogold particles are visible throughout the inclusion. The inclusion appears
to contain filamentous material (arrow) less electron dense than the surrounding nuclear material.
Abbreviations: n, nucleus; c, cytoplasm. Scale bars: (A) 2 mm, (B) 1 mm, (C) 650 nm.
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are studying the mice with 70 CAG repeats further to to perform aberrantly in behavioral tests. Furthermore,
frequent seizures (supra- or subconvulsive) may causedetermine if they develop abnormalities at a later age.
These behavioral similarities, in addition to the presence cumulative neuronal damage leading to progressive be-
havioral abnormalities in these animals.of NIIs, suggest that the pathology present in JO1 mice
shares a common molecular mechanism to the CAG/ One aspect of the human translated CAG repeat disor-
ders that has not been replicated in the JO1 mice is apolyglutamine repeat disorders of man.
striking macroscopic neurodegeneration (Ross, 1995).
These results are consistent with those seen in otherPossible Role of HPRT Deficiency
CAG repeat transgenic mice where phenotype precedesThe hprt(CAG)146 mutation inhibits or abolishes Hprt gene
degeneration (Orr and Zoghbi, 1996). Neurological dys-function to the extent that ES cells, which clearlyexpress
function without macroscopic neurodegeneration oc-hprt(CAG)146 gene products, grow well in media containing
curs in some cases of HD, suggesting that striking neu-6-thioguanine, a toxin to cells containing HPRT activity.
rodegeneration is not necessary for CAG repeats toAlthough HPRT deficiency causes Lesch-Nyhan syn-
cause a neurological disorder in humans (Vonsattel etdrome in humans, studies on HPRT-deficient mice have
al., 1985).failed to detect spontaneous behavioral abnormalities
Immunocytochemical analyses of JO1 mice show the(reviewed in Williamson et al., 1992). The HPRT protein
presence of NIIs. To date, these abnormal aggregatesis involved in purine salvage; however, HPRT-deficient
have been shown in three human repeat disorders,mice have normal levels of brain purines due to in-
SCA3, HD, and SCA1, as well as two transgenic mousecreased de novo purine synthesis and the use of an
models (Davies et al., 1997; DiFiglia et al., 1997; Paulsonalternate purine salvage pathway (Williamson et al.,
et al., 1997; Scherzinger et al., 1997; Skinner et al., 1997).1992; Jinnah et al., 1993). Several neurochemical mark-
The NIIs in JO1 mice and those reported earlier eachers in HPRT-deficient animals are normal; however, re-
show immunoreactivity to part of the disease proteinductions in dopamine, serotonin, and choline acetyl-
and to ubiquitin. That JO1 mice have these aggregatestransferase levels have been observed (Finger et al.,
shows that polyglutamines need not reside in a fragment1988; Dunnett et al., 1989; Jinnah et al., 1994). These
from one of the repeat disorder proteins in order toalterations do not result in obvious spontaneous behav-
produce NIIs. NIIs may be common to all of the CAG/ioral abnormalities; however, HPRT-deficient mice show
polyglutamine repeat disorders. Furthermore, a few cor-an increased sensitivity to amphetamines resulting in
relations between NIIs and neuronal dysfunction haveovergrooming and seizures in some animals (Jinnah et
been reported. First, in the several lines of mice trans-al., 1991). The use of HPRT-deficient controls in this
genic for a truncated HD transgene, only those with awork shows that HPRT deficiency alone is not responsi-
neurological phenotype have NIIs (Davies et al., 1997).ble for the phenotype of JO1 mice; however, it ispossible
Second, the distribution of NIIs in patients correlatesthat HPRT deficiency contributes to the abnormalities.
with affected neurons (DiFiglia et al., 1997; Paulson etSuch a compound phenotype is probably present in
al., 1997; Skinner et al., 1997). These correlations arethose patients with SBMA who exhibit both mild andro-
consistent with three widely divergent views of the rolegen insensitivity due to reductions in androgen receptor
that NIIs play in the pathology of CAG/polyglutamineactivity and progressive motor dysfunction due to long
repeat disorders. First, NIIs may be directly toxic (DaviesCAG repeats (Kazemi-Esfarjani et al., 1995). It is unlikely
et al., 1997; DiFiglia et al., 1997). Second, NIIs may formthat the HPRT deficiency in JO1 mice contributes sub-
in affected neurons coincidentally and play no role instantially tosusceptibility toseizures, increases in clasp-
the pathological process. Third, NIIs could be produceding, resting tremor, or abnormal movements, since these
by the cell as a defense against the toxic effects ofabnormalities are present in HD transgenic mice that
polyglutamine-containing proteins. Thus,NIIs mayservehave HPRT function (Mangiarini et al., 1996). HPRT-defi-
a beneficial role as a site of sequestration of a toxiccient controls used in this study were indistinguishable
protein. The distinction between these views is critical,from wild-type mice, with the exception that HPRT-defi-
since therapeutic strategies designed to prevent NII for-cient mice tended to clasp less and show more vertical
mation may actually prove harmful. Animal models suchactivity. These two effects are the opposite of those
as the one presented here will be necessary to test suchseen in JO1 mice, which show more clasping and less
therapies.vertical activity. Therefore, it is unlikely that the HPRT
deficiency in JO1 mice plays a major role in the abnormal
behaviors described here. The Role of Context
Although the genes for CAG/polyglutamine repeat disor-
ders are widely expressed, each of the CAG/polygluta-Neurological Aspects of the Phenotype
The most striking behavioral abnormality in the JO1 mice mine repeat disorders affects a different set of neurons
(Ross, 1995). The sequences surrounding the repeatis seizures. In humans with CAG repeats long enough
to cause the juvenile form of HD or DRPLA, seizures alter the toxic effect of the repeat in a tissue-specific
manner. This point is emphasized by the phenotypicare common (Quarrell and Harper, 1991). Seizures have
been reported in mice transgenic for a partial HD gene differences between mice with a partial HD transgene
(Mangiarini et al., 1996) and the JO1 line. Although bothwith an z150 unit CAG repeat (Mangiarini et al., 1996).
The other behavioral aspects of JO1 mice should be lines share a similar repeat length and widespread ex-
pression, mice with long repeats in the truncated HDviewed in light of their tendency to have seizures. It is
possible that subconvulsive seizures cause the mice gene progressively lose weight in contrast to JO1 mice,
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the precise insertion of a pure CAG repeat 438 bp long (146 CAGwhich increase in weight. There are several aspects of
repeat units).context that may play a role in modulating repeat toxic-
ity. The context may code for specific binding sites for
Production of Mice
proteins that mask or enhance the effects of the repeat. The gene-targeting construct was introduced to R1 ES cells (a gift
Such a binding site may be responsible for phenotypic from Andras Nagy [Nagy et al., 1993]) by electroporation and plated
differences between JO1 mice and mice with a partial onto ten 100 mm tissue culture plates with mitomycin C treated
embryonic fibroblast cell layers. Cells were grown without selectionHD transgene, since the region containing the polyglu-
for 5 days. On the fifth day, media was replaced with media con-tamine repeat of the HD protein has been shown to bind
taining 10 mM 6-thioguanine. Resistant colonies were screened byother proteins (Strittmatter et al., 1997).
Southern blot analysis of EcoRI-digested DNA using probe 1 (a gift
The role of context may, however, be far more simple. from N. Maeda). Gene targeting was confirmed by Southern analy-
Polyglutamines may be more toxic when they reside ses (shown in Figure 1). Targeted ES cells were injected into 3.5-day
in smaller proteins. Long polyglutamine repeats were embryos obtained from C57BL/6J mice, then transferred to the uteri
of pseudopregnant females to complete development. Resultingshown to be less toxic in vivo when expressed in a full-
chimeras were mated to C57BL/6J females to produce female carri-length SCA3 protein than when expressed in a truncated
ers of the X-linked hprt(CAG)146 mutant alleles. These heterozygousversion of the protein (Ikeda et al., 1996). Furthermore,
females were backcrossed to transmitting male chimeras to obtain
the in vitro formation of aggregates similar to NIIs has hemizygous males, heterozygous and homozygous females, and
been shown to be enhanced by the removal of nonpoly- wild-type males and females. All offspring from these matings were
glutamine portions of a protein (Scherzinger et al., 1997). genotyped by either Southern blot or by PCR using primers flanking
the repeat region.The presence of portions of disease protein in NIIs
brings up the intriguing possibility that a polyglutamine-
Western Blot Analysiscontaining protein needs access to the nucleus in order
R1 and targeted ES cell lines were grown to confluency on gelati-to be toxic. By this line of reasoning, polyglutamine-
nized 100 mm dishes in ES cell media. Cells were harvested and
containing proteins that cannot freely diffuse through resuspended in 1 ml SDS-PAGE buffer (0.1% SDS, 25 mM Tris, 250
nuclear pores (those greater than z50 kDa) would either mM glycine). Cell lysates were passed through a 26-gauge needle
have to be cleaved or transported to the nucleus to be several times, boiled 10 min, and centrifuged. Aliquots of the super-
natant were run on a 7.5% PAGE gel and electrotransferred to nitro-toxic. Cleavage of the normally cytoplasmic HD protein
cellulose. Membranes were hybridized with SL28 (Lobo Ruppert etto smaller polyglutamine-containing fragments already
al., 1996), 1C2 (Trottier et al., 1995) or anti-HPRT antibody. The anti-has been shown (Nasir et al., 1996; DiFiglia et al., 1997).
HPRT antibody against the peptide SVVISDDEPGY was made and
Therefore, another aspect of the HPRT protein that affinity purified by Research Genetics, Inc. (Huntsville, AL). Detection
might contribute to the phenotype in JO1 mice is its was performed using appropriate peroxidase-conjugated second-
small size (48 kDa with polyglutamine). ary antibody, enzymatic chemiluminescence (ECL kit, Amersham),
and autoradiography.Context might also alter the putative negative effects
of NIIs once present. For the NIIs already described and
Behavioral Analysisthose in JO1 mice, these aggregates include at least a
Hemizygous JO1 males (n 5 23) and homozygous JO1 females (n 5portion of the disease protein surrounding the polyglu-
13), their wild-type littermates (males 5 10 and females 5 7), and
tamine. Recent evidence from SCA1 transgenic mice hemizygous hprtb-m3 males (n 5 13) and homozygous hprtb-m3 females
and patients indicates that the mutantataxin-1 protein in (n 5 12) were housed separately during trials. Behavioral trials were
performed once a week for 10 weeks. Ages of the mice at theNIIs interacts with the nuclear matrix and other specific
beginning of the trials ranged from 8 to 25 weeks for JO1 and wild-proteins (Matilla et al., 1997; Skinner et al., 1997). These
type littermates and from 24 to 41 weeks for hprtb-m3 mice. Cagesinteractions may be responsible for the tissue-specific
were placed in a brightly lit laminar flow hood, and the tops wereeffects of expanded CAG/polyglutamine repeats of
removed. The activity of each mouse was scored as either active
SCA1. The importance of context in each CAG repeat (roaming in any part of the cage or rearing) or inactive (sitting or
disorder should not be underestimated. Although the lying without any roaming or rearing). Those that were scored as
inactive were then nudged with a finger. Inactive mice that remainedcontext of the repeat in the hprt(CAG)146 mutant allele might
still after nudging were scored as unresponsive. Mice were thenmake the JO1 line a poor model for any one particular
picked up by the tail and held suspended for 1 min. Clasping of theCAG repeat disorder, it will be valuable in assessing the
front and/or rear paws was scored as either present or absent. Forformation of NIIs and in testing therapies designed to
the rotarod experiments, mice were placed on a 4.0 cm diameter
attack a molecular mechanism shared by the disorders. rotarod rotating at 2.5 rpm 30 cm above a padded cage bottom.
Mice were scored as either falling or not falling within a 60 s trial.
At the end of each trial, mice were weighed. If a noticeable seizureExperimental Procedures
occurred at any point during the trial, the mouse was placed back
in its cage and no further tests were done on that mouse until theConstruction of Targeting Vector
The sequence 59TCGACGCTGGCACGTGCCGGGGAAGCTTCGTTA following week.
The undisturbed activity of mice was assessed by an infraredGTCGC39 was inserted into the unique XhoI site in exon 3 of the
murine Hprt locus, which had previously been cloned as a 7.0 kb beam activity monitor (A. B. Sieber, Rocky Mount, NC). One mouse
each was placed in a standard (29 cm length 3 19 cm width 3genomic BamHI fragment (a gift from N. Maeda). This insertion cre-
ated a unique PmlI site that allowed the addition of long CAG re- 13 cm height) Microisolator cage (Lab Products, Seaford, DE) with
enough food and water for 1 week. A total of eight beams spannedpeats. These repeats were synthesized by PCR using (CAG)20 and
(CTG)20 as both primer and template as previously described (Ord- the width of each cage. Six lower beams, evenly spaced (4.5 cm
apart, 2.5 cm from cage floor), would be broken by mice normallyway and Detloff, 1996). An additional 4.9 kb genomic BamHI frag-
ment, which included Hprt exon 4, was isolated from a 129 Sv/J walking the length of the cage, and two upper beams located near
the cage ends (1.8 cm from each cage wall and 7.0 cm above cagemouse genomic DNA Lambda library and added to the repeat-con-
taining construct. These manipulations resulted in a gene targeting floor) could only be broken by rearing or climbing upside-down on
the cage rack and could not be broken by mice feeding or drinking.construct with 11.9 kb of homology to the murine Hprt locus. Se-
quencing the entire repeat and surrounding sequences confirmed Each beam was checked for function before and after each trial.
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The apparatus simultaneously and continuously monitored beam of the SCA7 gene reveals a highly unstable CAG repeat expansion.
Nat. Genet. 17, 65±70.breaks for 20 cages over 6 days and nights. Day and night are
defined by a periodic 12 hr light and dark cycle, respectively. Data Davies, S.W., Turmaine, M., Cozens, B.A., DiFiglia, M., Sharp, A.H.,
was simultaneously recorded by an IBM personal computer pro- Ross, C.A., Scherzinger, E., Wanker, E.E., Mangiarini, L., and Bates,
grammed to store data at 2 min intervals for each of the beams. G.P. (1997). Formation of neuronal intranuclear inclusions underlies
This data was converted to an ASCII text file and analyzed by a the neurological dysfunction in mice transgenic for the HD mutation.
Microsoft Excel spreadsheet. Data from the first full day and full Cell 90, 537±548.
night was discarded to allow the mouse to acclimate to the fresh DiFiglia, M.,Sapp, E.,Chase, K.O., Davies,S.W., Bates, G.P., Vonsat-
cage. tel, J.P., and Aronin, N. (1997). Aggregation of Huntingtin in neuronal
intranuclear inclusions and dystrophic neurites in brain. Science
Histology 277, 1990±1993.
For brain analyses, mice were deeply anesthetized and perfused Dunnett, S.B., Sirinathsinghji, D.J., Heavens, R., Rogers, D.C., and
through the heart with a 0.1 M phosphate buffer (PB) rinse followed Kuehn, M.R. (1989). Monoamine deficiency in a transgenic (Hprt-)
by z100 ml of 4% paraformaldehyde in PB. The brains were cryopro- mouse model of Lesch-Nyhan syndrome. Brain Res. 501, 401±406.
tected in 30% sucrose, and 40 mm frozen sections were cut in Finger, S., Heavens, R.P., Sirinathsinghji, D.J., Kuehn, M.R., and
coronal or horizontal plane using a sliding microtome. Within 48 hr, Dunnett, S.B. (1988). Behavioral and neurochemical evaluation of a
the tissue was processed for either cresyl violet or immunohisto- transgenic mouse model of Lesch-Nyhan syndrome. J. Neurol. Sci.
chemical staining. For immunohistochemical assays, rabbit poly- 86, 203±213.
clonal primary antibodies to glial fibrillary acidic protein (1:100 dilu-
Gusella, J.F., McNeil, S., Persichetti, F., Srinidhi, J., Nevelletto, A.,tion, Vector Laboratories, Burlingame, CA), Ubiquitin (1:1000
Bird, E., Faber, P., Vansattel, J.-P., Myers, R.H., and MacDonald,dilution, Dako), or HPRT protein (1:2000 dilution, Research Genetics,
M.E. (1996). Huntington's disease. Cold Spring Harb. Symp. Quant.Huntsville, AL) were used for immunoperoxidase labeling for light
Biol. 61, 615±626.microscopy (Vectastain rabbit IgG Elite ABC kit, Vector Labora-
Hooper, M., Hardy, K., Handyside, A., Hunter, S., and Monk, M.tories). NIIs were visualized and counted at 4003 magnification
(1987). HPRT-deficient (Lesch-Nyhan) mouse embryos derived fromwith differential interference (Nomarski) optics. To approximate the
germline colonization by cultured cells. Nature 326, 292±295.proportion of neurons with inclusions, the number of NIIs in a non-
counterstained area was expressed as the proportion of cresyl- Ikeda, H., Yamaguchi, M., Sugai, S., Aze, Y., Narumiya, S., and
Kakizuka, A. (1996). Expanded polyglutamine in the Machado-violet stained neurons from the same area of an adjacent section.
Joseph disease protein induces cell death in vitro and in vivo. Nat.For EM analyses fixative included 0.15% glutaraldehyde, and immu-
Genet. 13, 196±202.nocytochemistry with 393-diaminobenzidine (DAB, Sigma) was per-
formed. Sections were then osmicated,stained overnight with uranyl Jinnah, H.A., Gage, F.H., and Friedmann, T. (1991). Amphetamine-
acetate, dehydrated, embedded in Eponate 12 (Ted Pella, Redding, induced behavioral phenotype in a hypoxanthine-guanine phospho-
CA), thin sectioned, and examined using a JEOL 100C electron ribosyltransferase-deficient mouse model of Lesch-Nyhan syn-
microscope. Immunogold labeling was performed using goat anti- drome. Behav. Neurosci. 105, 1004±1012.
mouse FAb fragments (1:50 dilution) conjugated to 1.4 nm gold Jinnah, H.A., Page, T., and Friedmann, T. (1993). Brain purines in a
particles (Nanoprobes, Inc., Stony Brook, NY). Sections were silver genetic mouse model of Lesch-Nyhan disease. J. Neurochem. 60,
intensified (Nanoprobes, Inc.), and thin sections were counter- 2036±2045.
stained with 5% uranyl acetate and Reynold's lead citrate. For the
Jinnah, H.A., Wojcik, B.E., Hunt, M., Narang, N., Lee, K.Y., Goldstein,analyses of all other organs, tissues were fixed for at least one day
M., Wamsley, J.K., Langlais, P.J., and Friedmann, T. (1994). Dopa-in 70% alcoholic formalin, treated with graded alcohols, cleared
mine deficiency in a genetic mouse model of Lesch-Nyhan disease.in xylenes, embedded in paraffin, processed into 5 mM sections,
J. Neurosci. 14, 1164±1175.
mounted on slides, and stained with hematoxylin and eosin.
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